阿必鲁肽

Albiglutide

未知生产厂商

Albiglutide is a GLP-1 agonist used to manage type 2 diabetes mellitus.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Albiglutide is a GLP-1 agonist used to manage type 2 diabetes mellitus.

作用机制

Albiglutide is an agonist of the GLP-1 (glucagon-like peptide 1) receptor and augments glucose-dependent insulin secretion. Albiglutide also slows gastric emptying.

适应症

用于2型糖尿病成年患者，作为饮食和运动的辅助疗法以改善血糖控制。不推荐用于饮食和运动控制不佳患者的一线治疗。

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

A METHOD FOR REVERSING AGING BRAIN FUNCTIONAL DECLINE
EP 4262873 A4申请人: UNIV HONG KONG CHINESE优先权: 2020
CN
EP
US
WO
5 件公开
Combination therapy comprising compounds of formula (I) and GLP-1 receptor agonists
US 12458612 B2申请人: GENFIT优先权: 2019
CN
EP
US
3 件公开
COMBINATION THERAPY FOR TREATING NEURODEGENERATIVE DISORDERS
WO 2025104674 A1申请人: ARIBIO CO LTD优先权: 2023
CN
WO
2 件公开
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US 9849066 B2申请人: CORNING INC优先权: 2014
US
2 件公开
COMPOSITIONS FOR DRUG ADMINISTRATION
US 2012021980 A1申请人: MAGGIO EDWARD T优先权: 2011
US
METHODS OF TREATMENT
US 2014378374 A1申请人: GLAXOSMITHKLINE IP NO 2 LTD优先权: 2014
US
Pharmaceutical compositions
CN 106659770 A申请人: GLAXOSMITHKLINE LLC优先权: 2014
CN
GLP-1 analogue and GC-C receptor agonist composite sustained release preparation and preparation method thereof
CN 107929718 A申请人: NANJING XINGYIN PHARMACEUTICAL GROUP CO LTD优先权: 2017
CN
Application of albiglutide to medicines for treating and preventing diabetic mellitus complicated with cerebral infarction
CN 109865128 A申请人: WANG MIN优先权: 2017
CN
阿必鲁肽在制备抗肿瘤免疫活化及肿瘤免疫治疗药物中的应用
CN 111744004 B申请人: 南京大学优先权: 2019
CN

药物

阿必鲁肽

概览

作用机制

适应症

相关疾病

专利